Medical Laboratory Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department by Country. 2017 to 2022 - Global Version

  • ID: 4393265
  • Report
  • Region: Global
  • 268 Pages
  • Howe Sound Research
1 of 5
Medical Laboratory Testing Services Reaches 12 Billion Tests Per Year. Genomic Technology And China Healthcare Expansion Driving Global Growth

FEATURED COMPANIES

  • Abbott Laboratories
  • Cancer Genetics, Inc.
  • DL Reference Laboratory
  • Grifols
  • Pathology Inc.
  • Schryver Medical
  • MORE

A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.

Trends like:

  • changing demographics
  • emerging economies and global prosperity
  • biotechnology advances in genetics
  • healthcare expansion in China
  • climate change
  • globalization
  • automation

Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

“Medical Laboratory Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department. 2017 to 2022 - Global Version" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2017 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Cancer Genetics, Inc.
  • DL Reference Laboratory
  • Grifols
  • Pathology Inc.
  • Schryver Medical
  • MORE

1. Introduction and Market Definition
1.1 The Growing Demand for Clinical Testing
1.2 Defining the Opportunity
1.2.1 Volumes
1.2.2 Prices
1.2.3 Revenue Market Size
1.3 Methods and Sources
1.3.1 Authors
1.3.2 Sources
1.4 U.S. Medical Market and Clinical Laboratory Testing - Perspective
1.3.1 U.S. Medicare Expenditures for Clinical Testing

2. Overview of a Dynamic Market
2.1 Market Players - Roles & Impacts
2.1.1 Supplier/pharmaceutical
2.1.2 Independent lab specialized/esoteric
2.1.3 Independent lab national/regional
2.1.4 Independent lab analytical
2.1.5 Public National/regional lab
2.1.6 Hospital lab
2.1.7 Physician lab
2.1.8 Audit body
2.2 Segmentation - Different Approaches
2.2.1 Traditional Market Segmentation
2.2.2 Laboratory Focus and Segmentation
2.3 Structure of Clinical Testing Industry
2.3.1 The Hospital Lab - Share of the Pie
2.3.2 Key Role for Economies of Scale
2.3.3 Physician Office Lab’s are Still Here
2.3.4 Physician’s and POCT - Reviving Patient Service in China
2.4 Profiles of Key Companies
2.4.1 Quest Diagnostics
2.4.2 Laboratory Corporation of America
2.4.3 Lifelabs Medical Laboratory Services
2.4.4 ACM Medical Laboratory
2.4.5 Spectra Laboratories, Inc.
2.4.6 Bio-Reference Laboratories, Inc.
2.4.7 CompuNet Clinical Laboratories, LLC
2.4.8 Genzyme Corporation
2.4.9 Sonic Healthcare Limited
2.4.10 Exagen Diagnostics, Inc.
2.4.11 Clongen Laboratories LLC
2.4.12 Clinical Reference Laboratory, Inc.
2.4.13 Mid America Clinical Laboratories, LLC
2.4.14 Miraca Life Sciences, Inc.
2.4.15 Psychemedics Corp.
2.4.16 Aurora Diagnostics, LLC
2.4.17 DL Reference Laboratory
2.4.18 Myriad Genetics, Inc.
2.4.19 Bioscientia Institut fuer Medizinische Diagnostik GmbH
2.4.20 Acibadem Labmed Laboratory
2.4.21 Eurofins Scientific
2.4.22 The Doctor’s Laboratory (Sonic Healthcare U.K.)
2.4.23 Pathology Inc.
2.4.24 Gribbles Pathology
2.4.25 B.P. CLINICAL LAB
2.4.26 Diagnósticos da América (DASA)
2.4.27 American Bio-Clinical Laboratories, Int'l
2.4.28 Adicon Clinical Laboratories
2.4.29 Dian Diagnostics
2.4.30 Kingmed Diagnostics
2.4.31 Ascend Clinical, LLC
2.4.32 Unilabs SA
2.4.33 American Pathology Partners, Inc.
2.4.34 Integrated Regional Laboratories, Inc.
2.4.35 Viracor Laboratories
2.4.36 Neogenomics
2.4.37 Genomic Health, Inc.
2.4.38 ARUP Laboratories, Inc.
2.4.39 Enzo Biochem, Inc.
2.5 National and Regional Diversity

3. Trends Driving a Changing Market
3.1 Growth Is Pushed From Many Sides
3.1.1 Understanding the Impact of Aging Population.
3.1.2 Economic growth a Key Driver
3.1.3 Point of Care Testing can increase demand
3.1.4 Alternative Medicine Creates Testing Opportunity
3.1.5 Esoteric Testing Moving Mainstream
3.1.6 Genetic Based Testing Creates New Department and New Discipline
3.2 Factors At Work To Shrink The Market
3.2.1 Lower costs trend to continue
3.2.2 Economic or population contraction.
3.2.3 Testing usage analysis curtailing growth.
3.2.4 Wellness has a downside
3.2.5 Test Displacement Impacts Important
3.2.6 Point of Care Testing
3.3 Automation
3.3.1 Stranded LIMS Investment
3.3.2 Software as a Service
3.3.3 Physician Office and Access Systems
3.4 Environment and Evolution
3.5 Diagnostic Technology Development
3.5.1  Next Generation Sequencing Fuels a Revolution
3.5.2 Impact of NGS on pricing
3.5.3 POCT/Self Testing Disruptive Force
3.5.4 Pharmacogenomics Blurs Diagnosis and Treatment
3.5.5 CGES Testing, A Brave New World
3.5.6 Molecular Diagnostics Technologies At The Forefront of Growth
3.5.7 Biochips/Giant magneto resistance based assay

4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments
4.1 Recent Developments - Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section
4.2 LabCorp explores acquisition of clinical trials firm PPD
4.3 Digipath Enters into Letter of Intent to Acquire Clinical Lab Companies
4.4 PSP to acquire European medical lab services company
4.5 Mars, Incorporated to Acquire VCA Inc.
4.6 Caprion Biosciences Acquires the Immune Monitoring Laboratory from ImmuneHealth
4.7 Takara Bio USA Holdings and Rubicon Genomics Announce Merger Agreement
4.8 Instrumentation Laboratory Acquires CA Casyso AG
4.9 Schryver Medical Completes Acquisitions of Professional Clinical Laboratory, Inc.
4.10 Grail, Illumina’s billion-dollar diagnostics startup
4.11 Grifols acquires Hologic’s blood screening unit for $1.85bn
4.12 Bio-Rad Laboratories to buy US firm RainDance Technologies
4.13 Abbott Laboratories to buy St. Jude Medical for $25 billion
4.14 CombiMatrix Gets Serious About Potential M&A Options in Wake of $8M Offering
4.15 Abbott to Acquire Alere, Becoming Leader in Point of Care Testing
4.16 Achieving Dx Ambitions Key to Avant-Amarantus-Theranostics Merger
4.17 LabCorp Agrees to Acquire Assets of Pathology Inc.
4.18 NeoGenomics Completes Acquisition of Clarient, Inc.
4.19 FDA Gets Pushback on Move to Regulate Lab Developed Tests
4.20 Cancer Genetics, Inc. Announces Partnership
4.21 Theranos plans to close all its clinical labs
4.22 Forte Capital Lowers stake in Laboratory Corp.
4.23 US Oncology Network Selects Myriad Genetics
4.24 Pyxant Labs Commences Clinical Laboratory Testing Services
4.25 Viewics Launches Diabetes Management
4.26 Alpha Genomix And Rx30 Partner
4.27 LabCorp Doubles Testing Capacity Of Covance
4.28 LabCorp to acquire clinical laboratories from Mount Sinai
4.29 PerkinElmer to buy Germany's Euroimmun for about $1.3 billion
4.30 LabCorp to Acquire Chiltern for Approximately $1.2 Billion in Cash
4.31 Precipio Diagnostics and Transgenomic Complete Merger
4.32 $550 Dock Turns a Smartphone into a Medical Lab
4.33 LabCorp & Interpace Extend Deal, Boost Cancer Portfolio

5. Country Market Sizes - North America 2014 to 2022
5.1 United States of America 2014 to 2022
5.1.1 Clinical Chemistry - Volumes, Prices, Revenues
5.1.2 Microbiology - Volumes, Prices, Revenues
5.1.3 Hematology - Volumes, Prices, Revenues
5.1.4 Anatomic Pathology - Volumes, Prices, Revenues
5.1.5 Molecular Diagnostics - Volumes, Prices, Revenues
5.1.6 All Clinical Testing - Volumes, Prices, Revenues
5.1.7 Cardiac Biomarkers - Volumes, Prices, Revenues
5.1.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
5.1.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
5.2 Canada 2014 to 2022
5.2.1 Clinical Chemistry - Volumes, Prices, Revenues
5.2.2 Microbiology - Volumes, Prices, Revenues
5.2.3 Hematology - Volumes, Prices, Revenues
5.2.4 Anatomic Pathology - Volumes, Prices, Revenues
5.2.5 Molecular Diagnostics - Volumes, Prices, Revenues
5.2.6 All Clinical Testing - Volumes, Prices, Revenues
5.2.7 Cardiac Biomarkers - Volumes, Prices, Revenues
5.2.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
5.2.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues

6. Country Markets - Europe 2014 to 2022
6.1 France 2014 to 2022
6.1.1 Clinical Chemistry - Volumes, Prices, Revenues
6.1.2 Microbiology - Volumes, Prices, Revenues
6.1.3 Hematology - Volumes, Prices, Revenues
6.1.4 Anatomic Pathology - Volumes, Prices, Revenues
6.1.5 Molecular Diagnostics - Volumes, Prices, Revenues
6.1.6 All Clinical Testing - Volumes, Prices, Revenues
6.1.7 Cardiac Biomarkers - Volumes, Prices, Revenues
6.1.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
6.1.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
6.2 Germany 2014 to 2022
6.2.1 Clinical Chemistry - Volumes, Prices, Revenues
6.2.2 Microbiology - Volumes, Prices, Revenues
6.2.3 Hematology - Volumes, Prices, Revenues
6.2.4 Anatomic Pathology - Volumes, Prices, Revenues
6.2.5 Molecular Diagnostics - Volumes, Prices, Revenues
6.2.6 All Clinical Testing - Volumes, Prices, Revenues
6.2.7 Cardiac Biomarkers - Volumes, Prices, Revenues
6.2.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
6.2.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
6.3 United Kingdom 2014 to 2022
6.3.1 Clinical Chemistry - Volumes, Prices, Revenues
6.3.2 Microbiology - Volumes, Prices, Revenues
6.3.3 Hematology - Volumes, Prices, Revenues
6.3.4 Anatomic Pathology - Volumes, Prices, Revenues
6.3.5 Molecular Diagnostics - Volumes, Prices, Revenues
6.3.6 All Clinical Testing - Volumes, Prices, Revenues
6.3.7 Cardiac Biomarkers - Volumes, Prices, Revenues
6.3.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
6.3.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
6.4 Spain 2014 to 2022
6.4.1 Clinical Chemistry - Volumes, Prices, Revenues
6.4.2 Microbiology - Volumes, Prices, Revenues
6.4.3 Hematology - Volumes, Prices, Revenues
6.4.4 Anatomic Pathology - Volumes, Prices, Revenues
6.4.5 Molecular Diagnostics - Volumes, Prices, Revenues
6.4.6 All Clinical Testing - Volumes, Prices, Revenues
6.4.7 Cardiac Biomarkers - Volumes, Prices, Revenues
6.4.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
6.4.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
6.5 Italy 2014 to 2022
6.5.1 Clinical Chemistry - Volumes, Prices, Revenues
6.5.2 Microbiology - Volumes, Prices, Revenues
6.5.3 Hematology - Volumes, Prices, Revenues
6.5.4 Anatomic Pathology - Volumes, Prices, Revenues
6.5.5 Molecular Diagnostics - Volumes, Prices, Revenues
6.5.6 All Clinical Testing - Volumes, Prices, Revenues
6.5.7 Cardiac Biomarkers - Volumes, Prices, Revenues
6.5.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
6.5.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
6.6 Russia 2014 to 2022
6.6.1 Clinical Chemistry - Volumes, Prices, Revenues
6.6.2 Microbiology - Volumes, Prices, Revenues
6.6.3 Hematology - Volumes, Prices, Revenues
6.6.4 Anatomic Pathology - Volumes, Prices, Revenues
6.6.5 Molecular Diagnostics - Volumes, Prices, Revenues
6.6.6 All Clinical Testing - Volumes, Prices, Revenues
6.6.7 Cardiac Biomarkers - Volumes, Prices, Revenues
6.6.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
6.6.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
6.7 Remainder of Europe and Former Soviet Union 2014 to 2022
6.7.1 Clinical Chemistry - Volumes, Prices, Revenues
6.7.2 Microbiology - Volumes, Prices, Revenues
6.7.3 Hematology - Volumes, Prices, Revenues
6.7.4 Anatomic Pathology - Volumes, Prices, Revenues
6.7.5 Molecular Diagnostics - Volumes, Prices, Revenues
6.7.6 All Clinical Testing - Volumes, Prices, Revenues
6.7.7 Cardiac Biomarkers - Volumes, Prices, Revenues
6.7.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
6.7.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues

7. Country Markets - Asia Pacific 2014 to 2022
7.1 China 2014 to 2022
7.1.1 Clinical Chemistry - Volumes, Prices, Revenues
7.1.2 Microbiology - Volumes, Prices, Revenues
7.1.3 Hematology - Volumes, Prices, Revenues
7.1.4 Anatomic Pathology - Volumes, Prices, Revenues
7.1.5 Molecular Diagnostics - Volumes, Prices, Revenues
7.1.6 All Clinical Testing - Volumes, Prices, Revenues
7.1.7 Cardiac Biomarkers - Volumes, Prices, Revenues
7.1.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
7.1.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
7.2 Japan 2014 to 2022
7.2.1 Clinical Chemistry - Volumes, Prices, Revenues
7.2.2 Microbiology - Volumes, Prices, Revenues
7.2.3 Hematology - Volumes, Prices, Revenues
7.2.4 Anatomic Pathology - Volumes, Prices, Revenues
7.2.5 Molecular Diagnostics - Volumes, Prices, Revenues
7.2.6 All Clinical Testing - Volumes, Prices, Revenues
7.2.7 Cardiac Biomarkers - Volumes, Prices, Revenues
7.2.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
7.2.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
7.3 South Korea 2014 to 2022
7.3.1 Clinical Chemistry - Volumes, Prices, Revenues
7.3.2 Microbiology - Volumes, Prices, Revenues
7.3.3 Hematology - Volumes, Prices, Revenues
7.3.4 Anatomic Pathology - Volumes, Prices, Revenues
7.3.5 Molecular Diagnostics - Volumes, Prices, Revenues
7.3.6 All Clinical Testing - Volumes, Prices, Revenues
7.3.7 Cardiac Biomarkers - Volumes, Prices, Revenues
7.3.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
7.3.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
7.4 India 2014 to 2022
7.4.1 Clinical Chemistry - Volumes, Prices, Revenues
7.4.2 Microbiology - Volumes, Prices, Revenues
7.4.3 Hematology - Volumes, Prices, Revenues
7.4.4 Anatomic Pathology - Volumes, Prices, Revenues
7.4.5 Molecular Diagnostics - Volumes, Prices, Revenues
7.14.6 All Clinical Testing - Volumes, Prices, Revenues
7.4.7 Cardiac Biomarkers - Volumes, Prices, Revenues
7.4.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
7.4.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
7.5 Australia 2014 to 2022
7.5.1 Clinical Chemistry - Volumes, Prices, Revenues
7.5.2 Microbiology - Volumes, Prices, Revenues
7.5.3 Hematology - Volumes, Prices, Revenues
7.5.4 Anatomic Pathology - Volumes, Prices, Revenues
7.5.5 Molecular Diagnostics - Volumes, Prices, Revenues
7.5.6 All Clinical Testing - Volumes, Prices, Revenues
7.5.7 Cardiac Biomarkers - Volumes, Prices, Revenues
7.5.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
7.5.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
7.6 Rest of Asia Pacific 2014 to 2022
7.6.1 Clinical Chemistry - Volumes, Prices, Revenues
7.6.2 Microbiology - Volumes, Prices, Revenues
7.6.3 Hematology - Volumes, Prices, Revenues
7.6.4 Anatomic Pathology - Volumes, Prices, Revenues
7.6.5 Molecular Diagnostics - Volumes, Prices, Revenues
7.6.6 All Clinical Testing - Volumes, Prices, Revenues
7.6.7 Cardiac Biomarkers - Volumes, Prices, Revenues
7.6.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
7.6.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues

8. Country Markets - Latin America, Africa & The Middle East 2014 to 2022
8.1 Brazil 2014 to 2022
8.1.1 Clinical Chemistry - Volumes, Prices, Revenues
8.1.2 Microbiology - Volumes, Prices, Revenues
8.1.3 Hematology - Volumes, Prices, Revenues
8.1.4 Anatomic Pathology - Volumes, Prices, Revenues
8.1.5 Molecular Diagnostics - Volumes, Prices, Revenues
8.1.6 All Clinical Testing - Volumes, Prices, Revenues
8.1.7 Cardiac Biomarkers - Volumes, Prices, Revenues
8.1.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
8.1.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
8.2 Mexico 2014 to 2022
8.2.1 Clinical Chemistry - Volumes, Prices, Revenues
8.2.2 Microbiology - Volumes, Prices, Revenues
8.2.3 Hematology - Volumes, Prices, Revenues
8.2.4 Anatomic Pathology - Volumes, Prices, Revenues
8.2.5 Molecular Diagnostics - Volumes, Prices, Revenues
8.2.6 All Clinical Testing - Volumes, Prices, Revenues
8.2.7 Cardiac Biomarkers - Volumes, Prices, Revenues
8.2.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
8.2.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
8.3 Remainder of Latin America 2014 to 2022
8.3.1 Clinical Chemistry - Volumes, Prices, Revenues
8.3.2 Microbiology - Volumes, Prices, Revenues
8.3.3 Hematology - Volumes, Prices, Revenues
8.3.4 Anatomic Pathology - Volumes, Prices, Revenues
8.3.5 Molecular Diagnostics - Volumes, Prices, Revenues
8.3.6 All Clinical Testing - Volumes, Prices, Revenues
8.3.7 Cardiac Biomarkers - Volumes, Prices, Revenues
8.3.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
8.3.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues
8.4 Africa & The Middle East 2014 to 2022
8.4.1 Clinical Chemistry - Volumes, Prices, Revenues
8.4.2 Microbiology - Volumes, Prices, Revenues
8.4.3 Hematology - Volumes, Prices, Revenues
8.4.4 Anatomic Pathology - Volumes, Prices, Revenues
8.4.5 Molecular Diagnostics - Volumes, Prices, Revenues
8.4.6 All Clinical Testing - Volumes, Prices, Revenues
8.4.7 Cardiac Biomarkers - Volumes, Prices, Revenues
8.4.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
8.4.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues

9. Global Market Summary 2014 to 2022
9.1 Global Market 2014 to 2022
9.1.1 Clinical Chemistry - Volumes, Prices, Revenues
9.1.2 Microbiology - Volumes, Prices, Revenues
9.1.3 Hematology - Volumes, Prices, Revenues
9.1.4 Anatomic Pathology - Volumes, Prices, Revenues
9.1.5 Molecular Diagnostics - Volumes, Prices, Revenues
9.1.6 All Clinical Testing - Volumes, Prices, Revenues
9.1.7 Cardiac Biomarkers - Volumes, Prices, Revenues
9.1.8 Molecular Diagnostic Oncology - Volumes, Prices, Revenues
9.1.9 Molecular Diagnostic Genetics - Volumes, Prices, Revenues

10. The Future of the Clinical Laboratory

Appendices
I. United States Medicare System: January 2017 Clinical Laboratory Fees Schedule - National Limit and Midpoint

Table of Tables
Table 1 Medicare Clinical Lab Expenditures Actual & Forecast 2004 to 2020 ($Billion)
Table 2  Market Players by Type
Table 3 Clinical Laboratory Departments and Segments
Table 4 Laboratory Management Focus - Different Approaches
Table 5 Key Segmentation Variables Going Forward
Table 6 Factors Affecting Local Clinical Testing Demand
Table 7 Seven Factors Driving Growth
Table 8 Alternative Medicine Creates New Clinical Testing Markets
Table 9 Six Factors Limiting Growth
Table 10 Key Diagnostic Laboratory Technology Trends
Table 11 Next Generation Sequencing Technologies - Speed and Cost
Table 12 Key Point of Care Testing Uses
Table 13 Clinical Application Areas for Molecular Diagnostics
Table 14 Clinical Chemistry - Volume Price and Revenue Forecast
Table 15 Microbiology - Volume Price and Revenue Forecast
Table 16 Hematology - Volume Price and Revenue Forecast
Table 17 Anatomic Pathology - Volume Price and Revenue Forecast
Table 18 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 19 All Clinical Testing - Volume Price and Revenue Forecast
Table 20 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 21 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 22 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 23 Clinical Chemistry - Volume Price and Revenue Forecast
Table 24 Microbiology - Volume Price and Revenue Forecast
Table 25 Hematology - Volume Price and Revenue Forecast
Table 26 Anatomic Pathology - Volume Price and Revenue Forecast
Table 27 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 28 All Clinical Testing - Volume Price and Revenue Forecast
Table 29 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 30 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 31 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 32 Clinical Chemistry - Volume Price and Revenue Forecast
Table 33 Microbiology - Volume Price and Revenue Forecast
Table 34 Hematology - Volume Price and Revenue Forecast
Table 35 Anatomic Pathology - Volume Price and Revenue Forecast
Table 36 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 37 All Clinical Testing - Volume Price and Revenue Forecast
Table 38 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 39 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 40 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 41 Clinical Chemistry - Volume Price and Revenue Forecast
Table 42 Microbiology - Volume Price and Revenue Forecast
Table 43 Hematology - Volume Price and Revenue Forecast
Table 44 Anatomic Pathology - Volume Price and Revenue Forecast
Table 45 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 46 All Clinical Testing - Volume Price and Revenue Forecast
Table 47 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 48 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 49 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 50 Clinical Chemistry - Volume Price and Revenue Forecast
Table 51 Microbiology - Volume Price and Revenue Forecast
Table 52 Hematology - Volume Price and Revenue Forecast
Table 53 Anatomic Pathology - Volume Price and Revenue Forecast
Table 54 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 55 All Clinical Testing - Volume Price and Revenue Forecast
Table 56 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 57 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 58 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 59 Clinical Chemistry - Volume Price and Revenue Forecast
Table 60 Microbiology - Volume Price and Revenue Forecast
Table 61 Hematology - Volume Price and Revenue Forecast
Table 62 Anatomic Pathology - Volume Price and Revenue Forecast
Table 63 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 64 All Clinical Testing - Volume Price and Revenue Forecast
Table 65 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 66 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 67 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 68 Clinical Chemistry - Volume Price and Revenue Forecast
Table 69 Microbiology - Volume Price and Revenue Forecast
Table 70 Hematology - Volume Price and Revenue Forecast
Table 71 Anatomic Pathology - Volume Price and Revenue Forecast
Table 72 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 73 All Clinical Testing - Volume Price and Revenue Forecast
Table 74 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 75 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 76 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 77 Clinical Chemistry - Volume Price and Revenue Forecast
Table 78 Microbiology - Volume Price and Revenue Forecast
Table 79 Hematology - Volume Price and Revenue Forecast
Table 80 Anatomic Pathology - Volume Price and Revenue Forecast
Table 81 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 82 All Clinical Testing - Volume Price and Revenue Forecast
Table 83 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 84 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 85 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 86 Clinical Chemistry - Volume Price and Revenue Forecast
Table 87 Microbiology - Volume Price and Revenue Forecast
Table 88 Hematology - Volume Price and Revenue Forecast
Table 89 Anatomic Pathology - Volume Price and Revenue Forecast
Table 90 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 91 All Clinical Testing - Volume Price and Revenue Forecast
Table 92 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 93 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 94 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 95 Clinical Chemistry - Volume Price and Revenue Forecast
Table 96 Microbiology - Volume Price and Revenue Forecast
Table 97 Hematology - Volume Price and Revenue Forecast
Table 98 Anatomic Pathology - Volume Price and Revenue Forecast
Table 99 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 100 All Clinical Testing - Volume Price and Revenue Forecast
Table 101 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 102 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 103 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 104 Clinical Chemistry - Volume Price and Revenue Forecast
Table 105 Microbiology - Volume Price and Revenue Forecast
Table 106 Hematology - Volume Price and Revenue Forecast
Table 107 Anatomic Pathology - Volume Price and Revenue Forecast
Table 108 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 109 All Clinical Testing - Volume Price and Revenue Forecast
Table 110 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 111 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 112 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 113 Clinical Chemistry - Volume Price and Revenue Forecast
Table 114 Microbiology - Volume Price and Revenue Forecast
Table 115 Hematology - Volume Price and Revenue Forecast
Table 116 Anatomic Pathology - Volume Price and Revenue Forecast
Table 117 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 118 All Clinical Testing - Volume Price and Revenue Forecast
Table 119 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 120 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 121 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 122 Clinical Chemistry - Volume Price and Revenue Forecast
Table 123 Microbiology - Volume Price and Revenue Forecast
Table 124 Hematology - Volume Price and Revenue Forecast
Table 125 Anatomic Pathology - Volume Price and Revenue Forecast
Table 126 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 127 All Clinical Testing - Volume Price and Revenue Forecast
Table 128 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 129 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 130 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 131 Clinical Chemistry - Volume Price and Revenue Forecast
Table 132 Microbiology - Volume Price and Revenue Forecast
Table 133 Hematology - Volume Price and Revenue Forecast
Table 134 Anatomic Pathology - Volume Price and Revenue Forecast
Table 135 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 136 All Clinical Testing - Volume Price and Revenue Forecast
Table 137 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 138 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 139 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 140 Clinical Chemistry - Volume Price and Revenue Forecast
Table 141 Microbiology - Volume Price and Revenue Forecast
Table 142 Hematology - Volume Price and Revenue Forecast
Table 143 Anatomic Pathology - Volume Price and Revenue Forecast
Table 144 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 145 All Clinical Testing - Volume Price and Revenue Forecast
Table 146 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 147 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 148 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 149 Clinical Chemistry - Volume Price and Revenue Forecast
Table 150 Microbiology - Volume Price and Revenue Forecast
Table 151 Hematology - Volume Price and Revenue Forecast
Table 152 Anatomic Pathology - Volume Price and Revenue Forecast
Table 153 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 154 All Clinical Testing - Volume Price and Revenue Forecast
Table 155 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 156 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 157 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 158 Clinical Chemistry - Volume Price and Revenue Forecast
Table 159 Microbiology - Volume Price and Revenue Forecast
Table 160 Hematology - Volume Price and Revenue Forecast
Table 161 Anatomic Pathology - Volume Price and Revenue Forecast
Table 162 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 163 All Clinical Testing - Volume Price and Revenue Forecast
Table 164 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 165 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 166 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 167 Clinical Chemistry - Volume Price and Revenue Forecast
Table 168 Microbiology - Volume Price and Revenue Forecast
Table 169 Hematology - Volume Price and Revenue Forecast
Table 170 Anatomic Pathology - Volume Price and Revenue Forecast
Table 171 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 172 All Clinical Testing - Volume Price and Revenue Forecast
Table 173 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 174 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 175 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 176 Clinical Chemistry - Volume Price and Revenue Forecast
Table 177 Microbiology - Volume Price and Revenue Forecast
Table 178 Hematology - Volume Price and Revenue Forecast
Table 179 Anatomic Pathology - Volume Price and Revenue Forecast
Table 180 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 181 All Clinical Testing - Volume Price and Revenue Forecast
Table 182 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 183 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 184 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 185 Clinical Chemistry - Volume Price and Revenue Forecast
Table 186 Microbiology - Volume Price and Revenue Forecast
Table 187 Hematology - Volume Price and Revenue Forecast
Table 188 Anatomic Pathology - Volume Price and Revenue Forecast
Table 189 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 190 All Clinical Testing - Volume Price and Revenue Forecast
Table 191 Cardiac Biomarkers - Volume Price and Revenue Forecast
Table 192 Molecular Diagnostic Oncology - Volume Price and Revenue Forecast
Table 193 Molecular Diagnostic Genetics - Volume Price and Revenue Forecast
Table 194 2017 Clinical Lab Fee Schedule

Table of Figures
Figure 1 Medicare Clinical Lab Expenditures 2004 to 2020 ($Million)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abbott Laboratories
  • Acibadem Labmed Laboratory
  • ACM Medical Laboratory
  • Adicon Clinical Laboratories
  • Alere
  • Alpha Genomix
  • American Bio-Clinical Laboratories, Int'l
  • American Pathology Partners, Inc.
  • ARUP Laboratories, Inc.
  • Ascend Clinical, LLC
  • Aurora Diagnostics, LLC
  • Avant-Amarantus-Theranostics
  • B.P. CLINICAL LAB
  • Bio-Rad Laboratories
  • Bio-Reference Laboratories, Inc.
  • Bioscientia Institut fuer Medizinische Diagnostik GmbH
  • CA Casyso AG
  • Cancer Genetics, Inc.
  • Caprion Biosciences
  • Chiltern
  • Clarient, Inc.
  • Clinical Lab Companies
  • Clinical Reference Laboratory, Inc.
  • Clongen Laboratories LLC
  • CombiMatrix
  • CompuNet Clinical Laboratories, LLC
  • Covance
  • Diagnósticos da América (DASA)
  • Dian Diagnostics
  • Digipath
  • DL Reference Laboratory
  • Enzo Biochem, Inc.
  • Eurofins Scientific
  • Euroimmun
  • Exagen Diagnostics, Inc.
  • Forte Capital
  • Genomic Health, Inc.
  • Genzyme Corporation
  • Grail
  • Gribbles Pathology
  • Grifols
  • Hologic
  • Illumina
  • ImmuneHealth
  • Instrumentation Laboratory
  • Integrated Regional Laboratories, Inc.
  • Kingmed Diagnostics
  • LabCorp
  • Laboratory Corporation of America
  • Lifelabs Medical Laboratory Services
  • Mars, Incorporated
  • Mid America Clinical Laboratories, LLC
  • Miraca Life Sciences, Inc.
  • Mount Sinai
  • Myriad Genetics, Inc.
  • NeoGenomics
  • Pathology Inc.
  • PerkinElmer
  • Precipio Diagnostics
  • Professional Clinical Laboratory, Inc.
  • PSP
  • Psychemedics Corp.
  • Pyxant Labs
  • Quest Diagnostics
  • RainDance Technologies
  • Rubicon Genomics
  • Rx30
  • Schryver Medical
  • Sonic Healthcare Limited
  • Spectra Laboratories, Inc.
  • St. Jude Medical
  • Takara Bio USA Holdings
  • The Doctor’s Laboratory (Sonic Healthcare U.K.)
  • Theranos
  • Transgenomic
  • Unilabs SA
  • VCA Inc.
  • Viewics
  • Viracor Laboratories
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll